Inotiv, Inc. (NOTV)

1.34 -0.03 (-2.09%)

As of 2025-10-16 16:33:10 EST

Inotiv, Inc. is a contract research organization organized in Indiana and headquartered in Lafayette, Indiana. The company operates two core business units: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The CRS business unit offers drug development and environmental sciences services, including safety assessment, analytical, metabolism, CMC and regulatory consultancy for small molecule drug candidates, biotherapeutics, and biomedical devices. The RMS business unit provides research models (live animals), lab animal diets and bedding and support services.

Traded asNasdaq: NOTV
ISINUS45783Q1004
CIK0000720154
LEI—
EIN351345024
SectorPharmaceutical industry
IndustryServices-Commercial Physical & Biological Research
CEO—
Employees1,200
Fiscal Year End0930
Address2701 KENT AVE, WEST LAFAYETTE, IN, 47906-1382
Phone3174634527
Websitehttps://www.inotiv.com/
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
NOTVInotiv, Inc.2025-10-16 16:33:101.34-0.03-2.09
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
NOTV0000720154Inotiv, Inc.US45783Q1004—351345024Nasdaq8731Services-Commercial Physical & Biological Research0930IN2701 KENT AVEWEST LAFAYETTEIN47906-1382UNITED STATESUS31746345272701 KENT AVENUE, WEST LAFAYETTE, IN, 47906-13822701 KENT AVE, WEST LAFAYETTE, IN, 47906-1382BIOANALYTICAL SYSTEMS INCPharmaceutical industry1974—1,200https://www.inotiv.com/252,228,89934,354,25134,354,251Inotiv, Inc. is a contract research organization organized in Indiana and headquartered in Lafayette, Indiana. The company operates two core business units: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The CRS business unit offers drug development and environmental sciences services, including safety assessment, analytical, metabolism, CMC and regulatory consultancy for small molecule drug candidates, biotherapeutics, and biomedical devices. The RMS business unit provides research models (live animals), lab animal diets and bedding and support services.2025-10-10 23:21:52
This is a preview of the latest data. Subscribe to access the full data.
NOTV Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
NOTV Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
2024252,228,899152,326,134152.474426,015,129224,3690.87
202399,902,765-383,163,235-79.31925,790,760184,1240.719
2022483,066,000310,841,000180.485425,606,6361,340,5375.5243
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
John P. DevineVice President, Director, Chief Executive Officer, President, Chief Financial Officer2012145,0000——0145,000
Lori PayneVice President2012150,46710,000——17,332200,119
Michael R. CoxChief Financial Officer, Vice President2011165,00020,000——0185,000
Anthony S. ChiltonChief Executive Officer, President, Director2011254,25669,936——49,450419,967
Alberto HidalgoVice President2011163,6000——0163,600
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
20241,977
20231,955
20222,099
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue490,739,000572,425,000547,656,000
Cost Of Revenue157,826,000153,677,000130,696,000
Gross Profit———
Research And Development Expenses———
General And Administrative Expenses77,034,000108,227,00082,436,000
Operating Expenses———
Operating Income-86,406,000-81,460,000-263,452,000
Net Income-108,445,000-105,140,000-337,018,000
Earnings Per Share Basic-4.19-4.1-13.84
Earnings Per Share Diluted-4.19-4.1-13.84
Weighted Average Shares Outstanding Basic25,897,00025,641,00024,354,000
Weighted Average Shares Outstanding Diluted25,897,00025,641,00024,354,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents21,432,00035,492,00018,515,000
Marketable Securities Current———
Accounts Receivable14,624,00017,211,00088,867,000
Inventories18,173,00056,102,00071,441,000
Non Trade Receivables2,602,0001,813,000366,000
Other Assets Current4,857,0006,822,0008,250,000
Total Assets Current163,413,000213,803,000232,977,000
Marketable Securities Non Current———
Property Plant And Equipment188,328,000191,068,000186,199,000
Other Assets Non Current11,773,00010,079,0007,524,000
Total Assets Non Current188,328,000191,068,000186,199,000
Total Assets781,361,000856,530,000962,900,000
Accounts Payable33,526,00032,564,00028,695,000
Deferred Revenue17,088,00018,933,00029,420,000
Short Term Debt3,538,0007,950,0007,979,000
Other Liabilities Current4,941,0005,239,00011,913,000
Total Liabilities Current119,042,000132,194,000164,099,000
Long Term Debt393,339,000389,142,000350,655,000
Other Liabilities Non Current34,963,0006,373,0006,477,000
Total Liabilities Non Current491,815,000455,846,000439,035,000
Total Liabilities610,857,000588,040,000603,134,000
Common Stock6,466,0006,406,0006,362,000
Retained Earnings-562,163,000-453,278,000-348,277,000
Accumulated Other Comprehensive Income1,412,000330,000-5,500,000
Total Shareholders Equity170,504,000269,154,000360,372,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization57,118,00054,717,00049,324,000
Share Based Compensation Expense6,740,0007,844,00024,202,000
Other Non Cash Income Expense———
Change In Accounts Receivable-14,168,000-9,550,00023,838,000
Change In Inventories-38,210,000-14,011,00035,198,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable613,0005,963,000-8,042,000
Change In Other Liabilities-26,562,0003,455,000-5,407,000
Cash From Operating Activities-6,805,00027,883,000-5,217,000
Purchases Of Marketable Securities———
Sales Of Marketable Securities———
Acquisition Of Property Plant And Equipment22,310,00027,503,00036,300,000
Acquisition Of Business———
Other Investing Activities02,367,000—
Cash From Investing Activities-16,832,000-28,755,000-333,722,000
Tax Withholding For Share Based Compensation———
Payments Of Dividends———
Issuance Of Common Stock——0
Repurchase Of Common Stock———
Issuance Of Long Term Debt035,000,0000
Repayment Of Long Term Debt—036,777,000
Other Financing Activities-3,871,0000-1,157,000
Cash From Financing Activities9,675,00015,872,000203,151,000
Change In Cash-14,060,00016,512,000-137,944,000
Cash At End Of Period21,432,00035,492,00018,515,000
Income Taxes Paid1,843,0007,146,000479,000
Interest Paid36,138,00035,459,00017,063,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share-4.19-4.1-13.84
Price To Earnings Ratio-0.4057-0.7512-1.2175
Earnings Growth Rate2.1951-70.3757-1,767.4699
Price Earnings To Growth Ratio-0.18480.01070.0007
Book Value Per Share6.583910.471114.7724
Price To Book Ratio0.25820.29411.1406
Ebitda-2,600,000-258,000-257,511,000
Enterprise Value419,469,900440,574,280750,483,900
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio2.32771.47530.9952
Capital Expenditures54,378,00059,586,000187,545,000
Free Cash Flow-61,183,000-31,703,000-192,762,000
Return On Equity-0.636-0.3906-0.9352
One Year Beta2.02361.982.1921
Three Year Beta2.08671.75250.9552
Five Year Beta1.16140.99620.8095
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Neff R MatthewDirector2025-10-012,000D145,102
Neff R MatthewDirector2025-09-022,000D147,102
Neff R MatthewDirector2025-08-012,000D149,102
Neff R MatthewDirector2025-07-012,000D151,102
Neff R MatthewDirector2025-06-022,000D153,102
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Christopher L. Jacobs2023-01-20NY27Sale2022-12-12—$1,001 - $15,000
Christopher L. Jacobs2022-09-09NY27Purchase2022-07-18—$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Monument Capital Management2025-09-3047,01032,4211.45
Rockwood Wealth Management, LLC2025-09-3014,50010,0001.45
Corient Private Wealth LLC2025-06-3044,22224,2981.82
OSAIC HOLDINGS, INC.2025-06-3024,35913,3851.8199
Squarepoint Ops LLC2025-06-3047,79326,2601.82
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
INVESCO EXCHANGE-TRADED FUND TRUST2025-07-31Invesco RAFI US 1500 Small-Mid ETFPRFZ75,530151,815.30.0064
PACE SELECT ADVISORS TRUST2025-07-31Class P2PAPTX-19,033-38,256.33-0.0138
PACE SELECT ADVISORS TRUST2025-07-31Class PPASPX-19,033-38,256.33-0.0138
PACE SELECT ADVISORS TRUST2025-07-31Class APASIX-19,033-38,256.33-0.0138
iSHARES TRUST2025-06-30iShares Micro-Cap ETFIWC49,82190,674.220.0111
This is a preview of the latest data. Subscribe to access the full data.